CN102356869B - 太子参原料粉的制备方法 - Google Patents
太子参原料粉的制备方法 Download PDFInfo
- Publication number
- CN102356869B CN102356869B CN2011102721896A CN201110272189A CN102356869B CN 102356869 B CN102356869 B CN 102356869B CN 2011102721896 A CN2011102721896 A CN 2011102721896A CN 201110272189 A CN201110272189 A CN 201110272189A CN 102356869 B CN102356869 B CN 102356869B
- Authority
- CN
- China
- Prior art keywords
- radix pseudostellariae
- raw material
- radix
- pseudostellariae
- irradiation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000002994 raw material Substances 0.000 title claims abstract description 17
- 239000000843 powder Substances 0.000 title claims abstract description 8
- 238000002360 preparation method Methods 0.000 title claims abstract description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 13
- 238000009461 vacuum packaging Methods 0.000 claims abstract description 12
- 238000012545 processing Methods 0.000 claims abstract description 9
- 238000000034 method Methods 0.000 claims abstract description 7
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 6
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 6
- 230000001954 sterilising effect Effects 0.000 claims description 13
- 239000007921 spray Substances 0.000 claims description 8
- 239000000428 dust Substances 0.000 claims description 6
- 101800000068 Antioxidant peptide Proteins 0.000 claims description 4
- 240000008042 Zea mays Species 0.000 claims description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 4
- 235000005822 corn Nutrition 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 235000012054 meals Nutrition 0.000 claims description 4
- 238000003672 processing method Methods 0.000 claims description 4
- 238000012216 screening Methods 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 238000012856 packing Methods 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 10
- 238000004140 cleaning Methods 0.000 abstract description 2
- 235000006708 antioxidants Nutrition 0.000 abstract 1
- 230000000249 desinfective effect Effects 0.000 abstract 1
- 238000003801 milling Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 11
- 239000003814 drug Substances 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 7
- 210000001124 body fluid Anatomy 0.000 description 6
- 239000010839 body fluid Substances 0.000 description 6
- XPFVYQJUAUNWIW-UHFFFAOYSA-N furfuryl alcohol Chemical compound OCC1=CC=CO1 XPFVYQJUAUNWIW-UHFFFAOYSA-N 0.000 description 6
- 235000013305 food Nutrition 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 4
- 235000003140 Panax quinquefolius Nutrition 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- YGSIRXHFAUFUEJ-GPTQDWHKSA-N 2-Methyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypyran-4-one Chemical compound O1C=CC(=O)C(O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1C YGSIRXHFAUFUEJ-GPTQDWHKSA-N 0.000 description 2
- 241000208340 Araliaceae Species 0.000 description 2
- 241000756943 Codonopsis Species 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000002929 anti-fatigue Effects 0.000 description 2
- 230000002180 anti-stress Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- DOIRQSBPFJWKBE-UHFFFAOYSA-N dibutyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- HYBBIBNJHNGZAN-UHFFFAOYSA-N furfural Chemical compound O=CC1=CC=CO1 HYBBIBNJHNGZAN-UHFFFAOYSA-N 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 239000004519 grease Chemical class 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- QUEBYVKXYIKVSO-UHFFFAOYSA-N m-propyltoluene Chemical compound CCCC1=CC=CC(C)=C1 QUEBYVKXYIKVSO-UHFFFAOYSA-N 0.000 description 2
- 229910052748 manganese Inorganic materials 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 239000011573 trace mineral Chemical class 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- SMRPGWBDLOQHOS-UHFFFAOYSA-N 5-[4,5-dihydroxy-6-(hydroxymethyl)-3-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxy-3,4-dihydroxy-6-[[9-hydroxy-4-(hydroxymethyl)-4,6a,6b,8a,11,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1H-picen-3-yl]oxy]oxane-2-carboxylic acid Chemical compound OC1C(O)C(O)C(C)OC1OC1C(OC2C(OC(C(O)C2O)C(O)=O)OC2C(C3C(C4C(C5(CCC6(C)C(O)CC(C)(C)CC6C5=CC4=O)C)(C)CC3)(C)CC2)(C)CO)OC(CO)C(O)C1O SMRPGWBDLOQHOS-UHFFFAOYSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 208000032467 Aplastic anaemia Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 108010069514 Cyclic Peptides Proteins 0.000 description 1
- 102000001189 Cyclic Peptides Human genes 0.000 description 1
- 206010020850 Hyperthyroidism Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical group CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 230000000496 anti-anoxic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- QXMNTPFFZFYQAI-IMDKZJJXSA-N beta-sitosterol 3-O-beta-D-glucopyranoside Natural products CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O[C@@H]5C[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)C QXMNTPFFZFYQAI-IMDKZJJXSA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- NPJICTMALKLTFW-OFUAXYCQSA-N daucosterol Chemical compound O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CC[C@@H](CC)C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NPJICTMALKLTFW-OFUAXYCQSA-N 0.000 description 1
- QDFKFNAHVGPRBL-UHFFFAOYSA-N daucosterol Natural products CCC(CCC(C)C1CCC2C1CCC3C2(C)CC=C4CC(CCC34C)OC5OC(CO)C(O)C(O)C5O)C(C)C QDFKFNAHVGPRBL-UHFFFAOYSA-N 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- YGSIRXHFAUFUEJ-UHFFFAOYSA-N maltol beta-D-O-glucopyranoside Natural products O1C=CC(=O)C(OC2C(C(O)C(O)C(CO)O2)O)=C1C YGSIRXHFAUFUEJ-UHFFFAOYSA-N 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- 238000004161 plant tissue culture Methods 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 150000003233 pyrroles Chemical class 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- -1 ring skin class Substances 0.000 description 1
- PPRSVUXPYPBULA-UHFFFAOYSA-N saponin A Natural products CC1(C)CCC2(CCC3(C)C(=CCC4C5(C)CCC(OC6OC(CO)C(O)C(O)C6=O)C(C)(C)C5CCC34C)C2C1)C(=O)O PPRSVUXPYPBULA-UHFFFAOYSA-N 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
本发明涉及一种太子参原料粉的制备方法。本发明以干太子参作为原料，经清洗、浸泡、沥干、磨粉、真空包装和灭菌步骤制成太子参原料制品。本发明在加工过程中加入抗氧化剂，并采用辐照进行灭菌消毒，有效的保证干太子参的作为食用和药用深加工符合质量要求的优质原料粉，满足工业化生产的需要。
Description
技术领域
本发明涉及一种太子参原料粉的制备方法。属于食品和中药材加工与保藏技术领域。
背景技术
太子参是一种味甘、微苦、性平归脾肺经，具有近似人参作用但力量较弱的食药同源的一味清补补品。
1.太子参的成分
太子参中含有氨基酸、微量元素、糖类、油脂类、皂甙、淀粉、脂肪酸类、磷酸类、环肤类、挥发油类等营养成分：
太子参中含有大量氨基酸，包括赖氨酸、苏氨酸、缬氨酸、亮氨酸、异氨酸、蛋氨酸、苯丙氨酸等七种人体必需氨基酸和精氨酸、组氨酸2种人体半必需氨基酸；
太子参中含有丰富的微量元素，包括Cu、Fe、Zn、Mn″、Ca、Mg、Se、Co、Na等，其中人体必需微量元素Fe、Cu、Zn、Mn、Ca等含量较高；
太子参经水提纯，得到太子参多糖PHP-A和PHP-B外，还分得蔗糖、麦芽糖等；
太子参中挥发油含量约6.2％，用GC-MS鉴定出吡咯、糠醛、糠醇、1-甲基-3-丙基苯、2-甲氧基-6(1-丙烯基>-酚、邻苯二甲酸二丁酯等12种化合物，其中以糠醇含量最高；
从太子参正丁醇部分经柱层析分得太子参皂甙A、尖叶丝石竹皂甙及胡萝卜甙、△’-豆甾-3β-烯醇3-O-β-D葡萄糖甙；
太子参中还含有甾醇类、脂肪酸类、油脂类、磷脂类、环肽类及甲莺尾素A、肌醇-3-甲醚等物质。
2.太子参功效特点
太子参味甘、微苦、性平、归脾肺经，有近似人参的作用，但力量较弱，是补气药中的一味清补之品，《中国药典》收载，太子参具有益气健脾，生津润肺之功效。近年来，有研究发现太子参具有提高机体免疫力功能。抗衰老和促进病愈等功效。《本草从新》说太子参能″治气虚、润肺燥、补脾土、消水肿、化痰止咳″，其特点是药力平和，以清补见长，临床应用往往能收到益气不升提，生津不助湿，扶正不恋邪，补虚不峻猛的效果。
3.太子参的应用
太子参为常用中药，(中国药典》收载，具有益气补脾，生津润肺之功效，临床常用于脾虚体倦、食欲不振、小儿体弱、消化不良、病后虚弱、气阴不足、自汗口渴、肺燥干咳等症。近年来，在研究太子参的成分、药理过程中发现太子参具有抗疲劳、抗应激作用、免疫促进作用、抗衰老和延长寿命等作用。临床上可用于治疗肝炎、糖尿病、冠心病、心绞痛、继发性再生障碍性贫血、白细胞减少症、甲亢、淋巴结核等难治病症。
太子参除了直接药用外，在保健饮料和食品上还具有广泛的用途。太子参富含氨基酸、多糖、多种矿物质、维生素、皂甙等营养成分，参与机体代谢，具滋补、强壮、补气健脾、生津润肺等功效，有助于病后体虚和消化功能的恢复。另外，具有抗疲劳、抗应激、耐缺氧、耐低温、抗病毒、增强机体免疫能力、延缓衰老、延长寿命等作用。另外，可以补益气阴，生津止渴，功效与人参相近，但药力薄弱，与党参相比，补气作用较弱，但生津养阴之力比党参强，有时可代西洋参使用。因此，太子参堪称老少皆宜的清补食品。
太子参作为药用和食用的原料目前仅采用太子参干品，其加工是将鲜太子参经晾晒或烘制加工成干品，太子参干品仍含有9％～12％的水分。自然状态下的太子参干品原料在运输和贮存过程会受到许多不利因素的影响，进而影响到太子参原料的质量。
太子参的深加工，无论是用作药品或是食品的产业化生产，因生产必须在有GMP合格证的厂房车间中进行，因而对进入生产环境的原料有相应的要求。
发明内容
本发明的目的是为太子参的药用和食用深加工提供一种经真空包装和辐照灭菌处理并符合GMP要求的又保持良好品质的干太子参粉状原材料。
本发明的技术方案是：
以太子参为原料经过清洗、浸泡、沥干、磨粉、真空包装和灭菌步骤制成，加工步骤如下：
(1)筛选：选取无尘土、干净、体表完整的干太子参作为原料，按太子参外观表象进行分级；
(2)喷洒：用质量百分比为0.5％～2.0％的玉米抗氧化肽溶液对太子参进行喷洒，不断翻动太子参，使太子参表面均被抗氧化剂溶液覆盖，但没有液体流下，再经晾干去除太子参表面的水份；
(3)采用传统粉碎加工方法将太子参打成约100目的太子参粉剂，也可根据要求采用气流超细粉碎设备加工成80％达到100μm左右的粉剂。
(4)真空包装：采用粉体真空包装机，将太子参装袋每袋50g～10kg，然后真空封口；
(5)灭菌：真空封孔后的太子参产品送入辐照房进行灭菌处理，其灭菌条件应符合《中华人民共和国药典》的相关要求，辐照选用电子加速器，剂量根据包装太子参的量确定，2～8KGY，但最大剂量不超过8KGY。
本发明的积极意义
本发明涉及一种太子参原料粉的制备方法。本发明以干太子参作为原料，经清洗、浸泡、沥干、磨粉、真空包装和灭菌步骤制成太子参原料制品。本发明在加工过程中加入抗氧化剂，并采用辐照进行灭菌消毒，有效的保证干太子参的作为食用和药用深加工符合质量要求的优质原料粉，满足工业化生产的需要。
具体实施方式
实施例1
(1)筛选：选取无尘土、干净、体表完整的干太子参作为原料，按太子参外观表象进行分级；
(2)喷洒：用质量百分比为0.5％～2.0％的玉米抗氧化肽溶液对太子参进行喷洒，不断翻动太子参，使太子参表面均被抗氧化剂溶液覆盖，但没有液体流下，再经晾干去除太子参表面的水份；
(3)采用传统粉碎加工方法将太子参打成约100目的太子参粉剂，再采用气流超细粉碎设备加工成80％达到100μm左右的粉剂。
(4)真空包装：采用粉体真空包装机，将太子参装袋每袋10kg，然后真空封口；
(5)灭菌：真空封孔后的太子参产品送入辐照房进行灭菌处理，辐照选用电子加速器，剂量根据包装太子参的量确定，2KGY，但最大剂量不超过8KGY。
实施例2
(1)筛选：选取无尘土、干净、体表完整的干太子参作为原料，按太子参外观表象进行分级；
(2)喷洒：用质量百分比为0.5％～2.0％的玉米抗氧化肽溶液对太子参进行喷洒，不断翻动太子参，使太子参表面均被抗氧化剂溶液覆盖，但没有液体流下，再经晾干去除太子参表面的水份；
(3)采用传统粉碎加工方法将太子参打成约100目的太子参粉剂。
(4)真空包装：采用粉体真空包装机，将太子参装袋每袋50g，然后真空封口；
(5)灭菌：真空封孔后的太子参产品送入辐照房进行灭菌处理，辐照选用电子直线辐照加速器，剂量为8KGY，但最大剂量不超过8KGY。
Claims (1)
1.一种太子参原料粉的制备方法，其特征是加工步骤如下：
（1）筛选：选取无尘土、干净、体表完整的干太子参作为原料，按太子参外观表象进行分级；
（2）喷洒：用质量百分比为0.5%～2.0%的玉米抗氧化肽溶液对太子参进行喷洒，不断翻动太子参，使太子参表面均被抗氧化剂溶液覆盖，但没有液体流下，再经晾干去除太子参表面的水份；
（3）采用传统粉碎加工方法将太子参打成100目的太子参粉剂，再采用气流超细粉碎设备加工成80%达到100μm的粉剂；
（4）真空包装：采用粉体真空包装机，将太子参装袋每袋10kg，然后真空封口；
（5）灭菌：真空封口后的太子参产品送入辐照房进行灭菌处理，辐照选用电子加速器，剂量根据包装太子参的量确定，2kGy～8kGy，最大剂量不超过8kGy。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011102721896A CN102356869B (zh) | 2011-09-14 | 2011-09-14 | 太子参原料粉的制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011102721896A CN102356869B (zh) | 2011-09-14 | 2011-09-14 | 太子参原料粉的制备方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102356869A CN102356869A (zh) | 2012-02-22 |
| CN102356869B true CN102356869B (zh) | 2013-06-12 |
Family
ID=45582294
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011102721896A Expired - Fee Related CN102356869B (zh) | 2011-09-14 | 2011-09-14 | 太子参原料粉的制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102356869B (zh) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104664532A (zh) * | 2015-03-20 | 2015-06-03 | 杨素华 | 太子参饮料及其制备方法 |
-
2011
- 2011-09-14 CN CN2011102721896A patent/CN102356869B/zh not_active Expired - Fee Related
Non-Patent Citations (3)
| Title |
|---|
| 盛勇等.超微粉碎技术在中药生产现代化中的应用优势及展望.《中国粉体技术》.2003,第9卷(第3期),第29-30页. |
| 超微粉碎技术在中药生产现代化中的应用优势及展望;盛勇等;《中国粉体技术》;20030630;第9卷(第3期);第29-30页 * |
| 黎观红等.抗氧化肽的应用.《食物蛋白源生物活性肽 基础与应用》.化学工业出版社,2010,(第1版),第158页. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102356869A (zh) | 2012-02-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103263448B (zh) | 用于发酵预处理改进银杏叶黄酮提取的发酵菌种及应用 | |
| KR100936457B1 (ko) | 한약재 추출액과 곡류 발효 조성물의 제조방법. | |
| CN103704788A (zh) | 一种发酵银杏粉及加工方法 | |
| CN104664532A (zh) | 太子参饮料及其制备方法 | |
| CN101589801A (zh) | 一种红参蜜片的制作工艺 | |
| CN104381991A (zh) | 一种破壁灵芝孢子粉灵芝胶囊及其制备方法 | |
| CN107114779A (zh) | 含人参茎叶总皂苷蛹虫草提取物的咀嚼片及制备方法 | |
| CN103564495B (zh) | 一种蜂胶和虫草菌丝粉组合物及制备和应用 | |
| CN105595351B (zh) | 一种具有稳态化调控血糖的营养产品及其制备方法和应用 | |
| CN102356869B (zh) | 太子参原料粉的制备方法 | |
| CN107095295A (zh) | 一种提升肾功能和血液功能的植物复合粉或片剂 | |
| CN103719855B (zh) | 一种营养食品及生产方法 | |
| CN102813193A (zh) | 一种虫草花青口服液及其制备方法 | |
| CN102885959A (zh) | 一种大蒜全素的制备方法及其应用 | |
| CN109043097A (zh) | 一种海参茯苓枸杞复合压片糖果及其制备方法 | |
| CN102274267B (zh) | 真空包装太子参制备方法 | |
| CN114949126B (zh) | 一种促进肠道有益菌增殖的中药组合物及其制备方法与应用 | |
| CN105558194A (zh) | 一种罗汉果石斛提取物复合茶及其制备方法 | |
| CN105361176A (zh) | 一种白果复合养生粉的制作方法 | |
| CN104824768B (zh) | 一种食用菌饮料的制备方法 | |
| CN106031491A (zh) | 猴头菇山楂饮料 | |
| CN100346806C (zh) | 冬虫夏草蜂王浆枸杞胶囊 | |
| CN101785826A (zh) | 一种浙贝母花微粉的制备方法 | |
| CN102150828A (zh) | 一种养肝护肝的无花果制剂 | |
| CN100379427C (zh) | 一种辅助提高人体免疫力的片剂产品 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20180613 Address after: 355300 No. 9, West yamen lane, Shuangcheng Town, Zherong County, Ningde, Fujian. Patentee after: Yang Mingjie Address before: 355300 No. 9, West yamen lane, Shuangcheng Town, Zherong County, Ningde, Fujian. Patentee before: Yang Suhua |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130612 |